# EDGAR Filing Document

**Accession Number:** 0002130071
**File Stem:** 0001683168-26-003031
**Filing Date:** 2026-4
**Character Count:** 11336
**Document Hash:** d1ca52267aa7115f393b8f3236a0c8c2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001683168-26-003031.hdr.sgml**: 20260417

**ACCESSION NUMBER**: 0001683168-26-003031

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260417

**DATE AS OF CHANGE**: 20260417

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DAVION HEALTHCARE PLC
- **CENTRAL INDEX KEY:** 0002039072
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** G4
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-95618
- **FILM NUMBER:** 26870152

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** THE CUBE BUILDING
- **STREET 2:** MONAHAN ROAD
- **CITY:** CORK
- **PROVINCE COUNTRY:** L2
- **ZIP:** T12 H1XY
- **BUSINESS PHONE:** 357 25040052

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** THE CUBE BUILDING
- **STREET 2:** MONAHAN ROAD
- **CITY:** CORK
- **PROVINCE COUNTRY:** L2
- **ZIP:** T12 H1XY
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Kaye Jack Harry
- **CENTRAL INDEX KEY:** 0002130071

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** THE CUBE
- **STREET 2:** MONAHAN RD
- **CITY:** CORK
- **PROVINCE COUNTRY:** L2
- **ZIP:** T12H1XY

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**DAVION HEALTHCARE PLC**

*(Name of Issuer)*

**ORDINARY SHARES of (euro)0.01 par value per share**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**JACK KAYE**<br>THE CUBE BUILDING<br>MONAHAN ROAD<br>CORK L2 T12 H1XY<br>353 21 212 9330

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**11/28/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**JACK HARRY KAYE** | Name of reporting person<br>**JACK HARRY KAYE** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X0** | Citizenship or place of organization<br>**X0** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**5163418.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**5163418.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**5163418.00** | Aggregate amount beneficially owned by each reporting person<br>**5163418.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**20.64%** | Percent of class represented by amount in Row (11)<br>**20.64%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**RALLINSON CORP** | Name of reporting person<br>**RALLINSON CORP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**WYOMING** | Citizenship or place of organization<br>**WYOMING** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**1245000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**1245000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1245000.00** | Aggregate amount beneficially owned by each reporting person<br>**1245000.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**4.99%** | Percent of class represented by amount in Row (11)<br>**4.99%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**CO** | Type of Reporting Person (See Instructions)<br>**CO** | |

---

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**RALLINSON LTD** | Name of reporting person<br>**RALLINSON LTD** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[ ] (a)<br>[x] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**G4** | Citizenship or place of organization<br>**G4** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**3860530.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**3860530.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**3860530.00** | Aggregate amount beneficially owned by each reporting person<br>**3860530.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**15.44%** | Percent of class represented by amount in Row (11)<br>**15.44%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**CO** | Type of Reporting Person (See Instructions)<br>**CO** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
ORDINARY SHARES of (euro)0.01 par value per share

**(b) Name of Issuer:**
DAVION HEALTHCARE PLC

**(c) Address of Issuer's Principal Executive Offices:**
THE CUBE BUILDING, MONAHAN ROAD, CORK, L2, T12 H1XY

**Item 4. Purpose of Transaction**

I acquired and hold the shares for investment and alignment as an executive, and except as CEO in the ordinary course, I have no present plans or proposals that would result in any of the enumerated actions - but I reserve the right to change my plans and make further purchases/sales depending on circumstances.

**Item 5. Interest in Securities of the Issuer**

**(a)**
As of the date of this Statement, Mr. Kaye may be deemed to beneficially own 10,268,948 Shares, representing approximately 42.0% of the outstanding Shares, based on 25,000,000 Shares outstanding as of April 5th 2026, as reported by the Issuer in Post Effective Amendment No4 filed with the SEC.

Mr. Kaye directly holds 5,163,418 Shares in his own name. Rallinson Corp directly holds 1,245,000 Shares, and Rallinson Ltd directly holds 3,860,530 Shares.

Because Mr. Kaye is the sole director and sole shareholder of each of Rallinson Corp and Rallinson Ltd, and their ultimate beneficial owner, Mr. Kaye may be deemed to beneficially own the Shares held by Rallinson Corp and Rallinson Ltd.

**(b)**
Mr. Kaye has sole voting and dispositive power with respect to the 5,163,418 Shares held directly by him and, by virtue of his position as sole director and sole shareholder of Rallinson Corp and Rallinson Ltd, sole power to direct the voting and disposition of the 1,245,000 Shares held by Rallinson Corp and the 3,860,530 Shares held by Rallinson Ltd. Rallinson Corp has sole voting and dispositive power over the 1,245,000 Shares held by it. Rallinson Ltd has sole voting and dispositive power over the 3,860,530 Shares held by it.

**(c)**
Except as set forth in this Statement, none of the Reporting Persons, and to the best knowledge of the Reporting Persons, none of the persons listed in Item 2 hereof, has effected any transaction in the Shares during the past 60 days.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

I as CEO of Davion Healthcare Plc, have agreed to an informal voluntary lockup of 90 days from the first day of listing.  Thereafter, any share transaction I make will be subject to Rule 144 conditions.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** JACK HARRY KAYE

**Signature:** /s/ Jack Kaye

**Name/Title:** Jack Kaye, Chief Executive Officer, Davion Healthcare Plc

**Date:** 04/17/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** RALLINSON CORP

**Signature:** /s/ Jack Kaye

**Name/Title:** Jack Kaye, beneficial owner of Rallinson Corp

**Date:** 04/17/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** RALLINSON LTD

**Signature:** /s/ Jack Kaye

**Name/Title:** Jack Kaye, beneficial owner of Rallinson Ltd

**Date:** 04/17/2026